Diabetes
Conference Coverage
Islet, kidney transplants boost survival in type 1 diabetes
“Although islet transplantation has previously been shown to improve glycemic control, compared with conventional insulin therapy in recent...
From the Journals
COVID booster may transiently raise glucose levels in T1D
“Clinicians, pharmacists, and other health care providers may need to counsel people with T1D to be more vigilant with glucose testing and insulin...
Conference Coverage
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized...
Conference Coverage
Heart attack deaths static in those with type 1 diabetes
“Clinicians have to be aware of the absence of the declined mortality trend in people with type 1 diabetes having a first-time myocardial...
Latest News
Diabetes patients satisfied with continuous glucose monitors
Overall, 90% agreed that most sensors were accurate, but just 79% and 78%, respectively, were satisfied with sensor performance on the first and...
Latest News
Night owls have higher risk of developing type 2 diabetes
Those with a preference for waking up later had a 72% higher risk for diabetes and were 54% more likely to have unhealthy lifestyle behaviors,...
Conference Coverage
Low-dose aspirin cuts type 2 diabetes risk in over-65s
“At this time, our findings are exploratory but ignite the debate of the important role that anti-inflammatory approaches may play in preventing...
From the Journals
Diabetes drug class appears to reduce recurrent gout flares
Previously associated with a lower incidence of gout, SGLT2 inhibitors for the first time also appear to reduce gout flare recurrence and excess...
Conference Coverage
Screening finds high rates of CVD in diabetes, COPD patients
The study tested a “very simple” symptom questionnaire as the initial screening phase, yet resulted in a CVD diagnostic rate that was two- to...
News from the FDA/CDC
FDA clears new capabilities for diabetes app BlueStar
The clearance enables the app-based platform to provide bolus insulin dose recommendations that are based on glucose and trend data from a...
Latest News
Medicare announces 10 drugs targeted for price cuts in 2026
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.